TSS
IMUX icon

Two Sigma Securities’s Immunic IMUX Stock Holding History

Two Sigma Securities’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,988
Closed -$32.8K – 2378
2024
Q3 		$32.8K Buy
1,988
+277
+16% +$3.94K ﹤0.01% 2423
2024
Q2 		$19K Buy
1,711
+589
+52% +$7.32K ﹤0.01% 2706
2024
Q1 		$14.8K Buy
+1,122
New +$14.6K ﹤0.01% 2711
2023
Q3 		– Sell
-1,435
Closed -$36K – 3185
2023
Q2 		$36K Buy
+1,435
New +$24.1K ﹤0.01% 2439
2023
Q1 		– Sell
-2,503
Closed -$35K – 2946
2022
Q4 		$35K Buy
+2,503
New +$68.3K ﹤0.01% 2207
2019
Q1 		– Sell
-29
Closed -$2K – 2125
2018
Q4 		$2K Sell
29
-110
-79% -$12.9K ﹤0.01% 2073
2018
Q3 		$15K Buy
+139
New +$363K ﹤0.01% 2472

Other funds holding IMUX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Securities's IMUX Position: Q4 2024 in Review

Two Sigma Securities sold out of Immunic (IMUX) in Q4 2024, closing a stake of 1,988 shares — an estimated $32.8K sold.

Two Sigma Securities first reported a position in IMUX in Q3 2018 and held it in 7 quarters. The position peaked at $36K in Q2 2023. 65 funds tracked by Wall St. Rank hold IMUX as of Q4 2024.

  • Two Sigma Securities reported no remaining Immunic position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Securities sold 1,988 Immunic shares in Q4 2024, an estimated $32.8K.
  • Two Sigma Securities first reported a position in Immunic in Q3 2018 and held it in 7 quarters.
  • Two Sigma Securities's Immunic position peaked at $36K in Q2 2023.
  • 65 funds tracked by Wall St. Rank held Immunic as of Q4 2024.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.